Home / Letter From The Editor (page 3)

Letter From The Editor

Nov. 13, 2021

Most of the time, whenever we hear a child has diabetes, the assumption is that it must be Type 1 diabetes. This seems logical based on past thinking; however, if you have watched the progression of Type 2 diabetes over the past 30 years, the one constant, regardless of treatment …

Read More »

Nov. 6, 2021

When we talked about a single medication that treated multiple defects of diabetes, we used to be referring to 1 pill containing 2 different medications. Good examples of this were Glucovance, which combined glyburide and metformin, or ActoplusMet, which combined pioglitazone and metformin. There were a lot of possible combo …

Read More »

Oct. 30, 2021

It has been almost 15 years since Symlin (pramlintide) was first approved as an amylin replacement. Amylin is a hormone that is produced in the beta cells of the pancreas and works to prolong gastric emptying time, reduce postprandial glucagon secretion, and reduce caloric intake. When a patient develops type …

Read More »

Oct. 23, 2021

Dalia Elabed, PharmD Candidate, University of South Florida, and Kandarp Mehta, MS, PharmD Candidate, University of Colorado, spent a lot of time the past two weeks focused on the SGLT-2, canagliflozin. They reviewed multiple studies, including DAPA-HF, EMPEROR-REDUCED, SOLOIST-WHF, CANVAS and CANVAS-R, to put together two very concise articles on …

Read More »

Oct. 16, 2021

We are now 18 months into the pandemic, and many researchers have been able to look at data on the relationship of diabetes and the coronavirus. This week, our team of interns have taken the time to find the latest information on how diabetes affects Covid outcomes (Laterpay feature), Covid’s …

Read More »

Oct. 9, 2021

We keep seeing more evidence on the value of GLP-1 agonists and SGLT-2 inhibitors on protection and improvement in cardio and renal outcomes. This week when Steve and I looked at features from our interns to publish, we selected multiple articles that show how these classes of drugs are making …

Read More »

Oct. 2, 2021

There is no doubt that we put a lot of focus on physical activity when it comes to diabetes. We do this based on the fact that physical activity burns glucose, and so levels tend to run lower and A1c’s improve. This week, our own Dr. Sheri Colberg takes a …

Read More »

Sept. 25, 2021

There always seems to be a battle of the best diabetes food plans. They often seem to conflict with each other at times, and too often we forget: it is not what we think is the best, but it is what our patients are willing to do. This week two …

Read More »

Sept. 18, 2021

When it comes to eating and diabetes, there seem to be a million strategies. These ideas include: early breakfast, late breakfast, no breakfast, keto breakfast, Mediterranean lunch, and so many more. These ideas are usually based on a small number of patients who are overly zealous in their behavior. This …

Read More »

Sept. 11, 2021

Steve and I have been working with Doctor of Pharmacy Candidates for the past 15 years, and each and every time we discuss diabetes with a new student, we talk about the incidence of diabetes and then we talk about the even higher incidence of prediabetes. I believe that at …

Read More »